8-K
Current Report
Protara Therapeutics, Inc. Filed Acc 0001104659-20-003115
Acquisition or sale completed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shareholder vote results · Director nominations · Other events
- Item 2.01 Completion of acquisition or disposition of assets
- Item 5.01 Changes in control of the registrant
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 5.05 Amendment to or waiver of the code of ethics
- Item 5.07 Submission of matters to a vote of security holders
- Item 5.08 Shareholder director nominations
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading tm201618d1_8k.htm…